As of 2026-03-17, the Relative Valuation of Mersana Therapeutics Inc (MRSN) is (320.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.08 USD, the upside of Mersana Therapeutics Inc based on Relative Valuation is -1201.3%.
The range of the Relative Valuation is (287.61) - (338.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 26.5x | 23.4x |
| Forward P/E multiples | 20.5x - 24.2x | 22.3x |
| Fair Price | (287.61) - (338.91) | (320.27) |
| Upside | -1089.0% - -1265.4% | -1201.3% |
| Date | P/E |
| 2026-01-05 | -2.07 |
| 2026-01-02 | -2.07 |
| 2025-12-31 | -2.06 |
| 2025-12-30 | -2.04 |
| 2025-12-29 | -2.05 |
| 2025-12-26 | -2.07 |
| 2025-12-24 | -2.08 |
| 2025-12-23 | -2.07 |
| 2025-12-22 | -2.06 |
| 2025-12-19 | -2.06 |
| 2025-12-18 | -2.08 |